2663 Hits
2663 Hits
WP IP
News and commentary on IP issues
2324 Hits
2324 Hits
3345 Hits
3345 Hits
3610 Hits
3610 Hits
3006 Hits
3006 Hits
3475 Hits
3475 Hits
3010 Hits
3010 Hits
As of 1 January 2021, a UK, Gibraltar or Channel Islands address for service will be required for any new UK IP rights. This change has received parliamentary approval and is implemented in a UK IPO notice (TPN 2/2020) dated 21 December 2020. Action should be taken and we would be very happy to assist. If your IP rights are&nbs...
3960 Hits
3960 Hits
We are delighted that the UK Court of Appeal has today granted Dr Thaler the right to appeal the DABUS decision, which involves the important issue of patentability of inventions created by AI systems. Williams Powell is handling the DABUS patent applications as well as the UK and EPO appeals. The cases had been rejected by the UK High Court. The o...
3215 Hits
3215 Hits
As of January 2021, parties will no longer have free choice on whether a hearing (oral proceedings) during examination or opposition is in person or via video conferencing before the European Patent Office (EPO). Video conferences will be the default. 12 months ago, we would have had to fight for a hearing (oral proceedings) to be held with t...
3091 Hits
3091 Hits
A Supplementary Protection Certificate (SPC) can provide up to five years additional protection for a patented active ingredient of a pharmaceutical product that has received a marketing authorisation. The objective is to compensate a patent holder for the delay in being able to use the patent by the need to obtain the marketing authorisation. An S...
2057 Hits
2057 Hits
We have previously written about our involvement in filing and prosecuting patent applications for two inventions created by the AI inventor DABUS, and naming DABUS (the true deviser of the inventions) as the inventor.The UK IPO found the inventions to be both novel and inventive, and therefore, in principle, protectable by patent. ...
2416 Hits
2416 Hits
On 20 July 2020, the UK Government announced its official withdrawal from the Unified Patent Court (UPC) Agreement. This is a disappointment but not unexpected. Does this mark an end to over 40 years of efforts to produce a harmonised IP litigation process in Europe? Of course not. The UPC has, in recent year...
2830 Hits
2830 Hits
Ever since the Decision issued back in 1997 in the case of Biogen v Medeva the concept of insufficiency has been extended, particularly in the chemical and biotech fields, to include claims that have "excessive breadth" (so-called "Biogen insufficiency"). The Courts in the UK have applied this frequently to revoke patents that they decide clai...
3013 Hits
3013 Hits
Regeneron Pharmaceuticals' European patent EP 1360287 and its divisional EP 2264163 relate to methods of producing transgenic mice able to produce antibodies having human sequences, and the mice produced thereby. These patents covered the idea of producing mice having mixed human-murine gene sequences that could be subsequently modified t...
3134 Hits
3134 Hits
The European patent office has announced here that until 31 August 2020, no surcharge is payable for late paid renewal fees. This provision applies to EPO renewal fees having a deadline (without extension) between 15 March 2020 and 30 August 2020. Cases falling into this provision, will be deemed validly paid if the renew...
2645 Hits
2645 Hits
3391 Hits
3391 Hits
The European Patent Office's Enlarged Board of Appeal, decided that "dynamic interpretation" on legal issues is possible and has issued a ruling that reverses its previous position and significantly changes the patentability of plants, plant materials and animals at the European Patent Office. The Enlarged Board of Appeal, ...
16300 Hits
16300 Hits
On Friday 20 March 2020 the German Federal Constitutional Court dealt a blow to the Unified Patent Court (UPC), issuing a decision to uphold a constitutional complaint lodged against the German ratification of the UPC agreement. The complainant (a German patent attorney), had argued that the ratification of the UPC agreement was contrary to the Ger...
2641 Hits
2641 Hits
The European Patent Office (EPO) has announced its biennial fee increases. These take effect from 1 April 2020. Details can be found here. As in the past, the majority of the increases are explained to be inflationary with an average increase of 4-5%. An notable exception is the appeal fee, which will be increasi...
2480 Hits
2480 Hits
©
2007 - 2024
Williams Powell
All rights reserved.
Williams Powell are regulated by IPREG whose code of conduct can be found here.These pages aim to provide a source of information for both non-professional enquirers e.g. inventors and their companies in the U.K. and professional consultants and advisers throughout the rest of the world. The pages are not intended to provide legal advice, which will only be provided on direct application to us in the formal context of a client/attorney relationship.
The information provided is correct to the best of our knowledge and belief, but is provided without obligation or guarantee. It will be updated from time to time as needed.